However, the epidemic is progressing throughout French territory and new variants (in particular . Infect. Please courtesy: "J. Taylor Hays, M.D. Qeios. sharing sensitive information, make sure youre on a federal In response to the CMAJ News article by Lauren Vogel,1 we would like to highlight a method of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is underrecognized in Canada.. A hookah (shisha or waterpipe) is a single- or multistemmed instrument that has been used for smoking various flavoured substances, such as cannabis, tobacco and opium, for centuries and is . 8600 Rockville Pike This was likely due to the small sample size with only 55 participants, of whom 20 were smokers. 2023 Jan 1;15(1):e33211. Zhou Epub 2020 Jul 2. COVID-19 Resource Centre 2020. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed. Evidence from other outbreaks caused by viruses from the same family as COVID-19 suggests that tobacco smoking could, directly or indirectly, contribute to an increased risk of infection, poor prognosis and/or mortality for infectious respiratory diseases [39] [40]. Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States. Thirty-four peer-reviewed studies met the inclusion criteria. 2020. https://doi.org/10.32388/FXGQSB 8. Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey JMIR Public Health Surveill 2021;7(4):e27091 doi: 10.2196/27091 PMID: 33668011 PMCID: 8081027 Such studies are also prone to significant sampling bias. Review of: Smoking, vaping and hospitalization for COVID-19. This is quite remarkable, considering that smoking is the most important risk factor for COPD, causing up to 80% of all cases30. Zhao, Q. et al. When we look more closely at specific patient groups in the data, we see that, of the 24 included chronic obstructive pulmonary disorder (COPD) patients, only 3 had ever smoked (12.5%); the other 21 patients are found in the category smoking status never/unknown11. Third, since exposure to health misinformation on social media is more common among youth and young adults6, primary HCPs may choose to actively bring up the subject of smoking and COVID-19 in consultations with youth and young adults and advise non-smokers to never start smoking. The origins of the myth. 2020. Chen Q, Zheng Z, Zhang J. Respir. relationship between smoking and severity of COVID-19. The report was published May 12, 2020, in Nicotine & Tobacco Research. https://www.biorxiv.org/content/10.1101/2020.11.23.394577v3 (2020). association between smoking and ICU admission and mortality amongst 226 patients in Toronto, Canada. J. Prevalence and Persistence of Symptoms in Adult COVID-19 Survivors 3 and 18 Months after Discharge from Hospital or Corona Hotels. 182, 693718 (2010). Guo et al., 39 however, later identified errors in the 2020;75:107-8. https://doi.org/10.1016/j.ejim.2020.03.014 39. Background Conflicting evidence has emerged regarding the relevance of smoking on risk of COVID-19 and its severity. is one of the largest Chinese studies on smoking and COVID-19, with data on 1590 patients from 575 hospitals across China11. Investigative Radiology. Accessibility Clinical features and treatment of COVID-19 patients in northeast Chongqing. "Our communities . After reviewing data from 6,717 adults who received hospital care for COVID-19, researchers found adults who used tobacco or electronic cigarettes were more likely to experience . Annals of Palliative Medicine. 2020 Jul;8(7):664-665. doi: 10.1016/S2213-2600(20)30239-3. Epub 2020 Jun 16. N Engl J Med. None examined tobacco use and the risk of infection or the risk of hospitalization. A HCPs advice for smoking cessation has always been very important, but in these COVID-19 times it is more urgent than ever before. 2020;382(18):1708-20. https://doi:10.1056/NEJMoa2002032 14. For the majority, the increased stress of a potentially fatal disease, possibility of loss of employment, feelings of insecurity, confinement, and boredom, could increase the desire to smoke. meta-analyses that were not otherwise identified in the search were sought. However, researchers weren't sure about the impact smoking had on the severity of COVID-19 outcomes. Huang, C. et al. The tobacco epidemic is set to continue, despite assurances from many tobacco companies that smoke-free devices are safer than traditional cigarettes. We use cookies to help provide and enhance our service and tailor content and ads. B, Zhao J, Liu H, Peng J, et al. Fontanet A, Tondeur L, Madec Y, Grant R, Besombes C, Jolly N, et al. They reported only 5% of current daily smokers in their patient group. Clin. 2022 Nov 22;10:985494. doi: 10.3389/fpubh.2022.985494. The harms of tobacco use are well-established. Global Burden of Disease: GBD Compare Tool, 2020 (Available from: https://vizhub.healthdata.org/gbd-compare/) Accessed: April 27 2020. Abstract. Further, most studies did not make statistical adjustments to account for age and other confounding factors. Coronavirus symptoms: 10 key indicators and . nicotine replacement therapies and other approved medications. "I think the reasonable assumption is that because of those injuries to local defenses and the information we have from other respiratory infections, people who smoke will be at more risk for more serious COVID-19 infection and more likely to get even critical disease and have to be hospitalized.". C, Zhang X, Wu H, Wang J, et al. Although likely related to severity, there is no evidence to quantify the risk to smokers However, the battle against tobacco use should continue, by assisting smokers to successfully and permanently quit. Emerg. A number of recent studies have found low percentages of smokers among COVID-19 patients, causing scientists to conclude that smokers may be protected against SARS-CoV-2 infection. A Paris hospital network study suggests that regular smokers may be safer from COVID-19 infection than the general public, according to reports by Radio France Internationale and the Guardian . Internet Explorer). Crit. The researchers estimated the risks and excess burden of cardiovascular outcomes per 1000 persons 12 months after COVID-19 using electronic medical record data from 3 large cohorts: First, many critically ill COVID-19 patients have severe comorbidities that may exclude them from being admitted to a hospital or intensive care unit. Clinical Infectious Diseases. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China. on COVID-19. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Factors associated with anxiety in males and females in the Lebanese population during the COVID-19 lockdown. Addiction (2020). The Lancet Oncology. ScienceDaily, 5 October 2022. The IP address used for your Internet connection is part of a subnet that has been blocked from access to PubMed Central. Acad. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. First, every smoker should be encouraged to stop, be provided with advice, support, and pharmacotherapy, if available; times of crisis can often provide the impetus to stop smoking. "Past research has shown that smoking increases the risk of COVID-19 disease severity, but the risk of infection had been less clear," said UC Davis tobacco researcher and lead author of the study Melanie Dove. Epub 2020 May 25. 161, D1991 (2017). 2020;368:m1091. Several reports have claimed a smoker's paradox in coronavirus disease 2019 (COVID-19), in line with previous suggestions that smoking is associated with better survival after acute myocardial infarction and appears protective in preeclampsia. The connection between smoking, COVID-19. In this article, we shed light on the process that resulted in the misinterpretation of observational research by scientists and the media. "Smoking increases the risk of illness and viral infection, including type of coronavirus." with Coronavirus Disease 2019 (COVID-19) Outside Wuhan. been published which pooled the prevalence of smokers in hospitalized patients across studies based in China. 1. Use the Previous and Next buttons to navigate the slides or the slide controller buttons at the end to navigate through each slide. Publishers note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Clinical course and risk factors Second, primary HCPs can inform patients about the harmful relationship between smoking, COVID-19 and other serious illnesses, for example, by addressing the issue on their website or on posters/television screens in the waiting room. Changeux J, Amoura Z, Rey F, Miyara M. A nicotinic hypothesis for Covid-19 withpreventive and therapeutic implications. Prevalence of Underlying Diseases in Hospitalized Patients with COVID19: A Systematic Review and Meta-Analysis. 2019;30(3):405-17. https://doi.org/10.1097/EDE.0000000000000984 5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 17. However, 27 observational studies found that smokers constituted 1.4-18.5% of hospitalized adults. Induc. Alterations in the smoking behavior of patients were investigated in the study. If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. 2020;395(10229):1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3 30. DOI: https://doi.org/10.1016/S2213-2600(20)30239-3. https://ggtc.world/2020/03/24/covid-19-and-tobacco-industry-interference-2020/ (2020). official website and that any information you provide is encrypted Tobacco causes 8 million deaths every year from cardiovascular diseases, lung disorders, cancers, diabetes, and hypertension.1 Smoking tobacco is also a known risk factor for severe disease and death from determining risk factor and disease at the same time). Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Grundy, E. J., Suddek, T., Filippidis, F. T., Majeed, A. 2020. The meta-analysis by Emami et al. ScienceDaily. National and . In a meta-analysis of studies that included 11,590 COVID patients, researchers found that among people with the virus, the risk of disease progression in those who currently smoke . Methods We searched PubMed and Embase for studies published from January 1-May 25, 2020. 55: 2000547 https://doi.org/10.1183/13993003.00547-2020 13. Text the word "QUIT" (7848) to IQUIT (47848) for free help. Hu L, Chen S, Fu Y, Gao Z, Long H, Wang JM, et al. 2023 Jan 25;21:11. doi: 10.18332/tid/156855. "Smoking, vaping, hand-to-mouth social behavior, probably not distanced, unmasked, and exhaling and inhaling deeply, creating an aerosol of droplets those are all the ways that we know it gets spread. Reep-van den Bergh, C. M. M., Harteloh, P. P. M. & Croes, E. A. Doodsoorzaak nr. 2020 Oct;34(10):e581-e582. Based on the earlier work of E.A.C., N.A.v.W.-L. wrote the first and subsequent versions of the manuscript. Epidemiology. Sheltzer, J. Gut. French researchers are trying to find out. 22, 4955 (2016). To summarize, smoking is known to increase TB infection and also adversely affect treatment outcomes in TB making it a deadly duo. 2020;133(9):1032-8. https://doi.10.1097/CM9.000000000000775 23. Med.) Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. COVID-19 outcomes were derived from Public Health . These include conventional cigarettes (CCs), heated tobacco products (HTPs), and electronic cigarettes (ECs). An updated version of this meta-analysis which included an additional Journal of Clinical Virology. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. In South Africa, before the pandemic, the. Smoking also reduces our immunity, and makes us more susceptible to . also found an unusually low number of smokers among patients with a cardiovascular or cerebrovascular disease11. Current smokers have. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Get the latest science news in your RSS reader with ScienceDaily's hourly updated newsfeeds, covering hundreds of topics: Keep up to date with the latest news from ScienceDaily via social networks: Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Recently, a number of observational studies found an inverse relationship between smoking and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019 (COVID-19)), leading to a (social) media hype and confusion among scientists and to some extent the medical community. Federal government websites often end in .gov or .mil. Bookshelf Bone Jt. This has led to claims that a 'smoker's paradox' may exist in COVID-19, wherein smokers are protected from infection and severe complications of COVID-19 . According to a peer reviewer of a different study, unknown can be explained by the fact that many patients were too ill to answer the questions about smoking29. SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint? . Breathing in any amount of smoke is bad for your health. The best way to stop smoking is to talk to your health care provider,make a planand stick to it, using many of the resources available, such as behavioral therapy and medications. Infect. 31, 10 (2021). The risk of transmitting the virus is . (2022, October 5). There are currently no peer-reviewed studies that directly estimate the risk of hospitalization with COVID-19 among smokers. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. "This finding suggests . Due to the preliminary nature of the many non-peer-reviewed reports issued during the COVID-19 pandemic, preprint repositories were deliberately excluded from this review. Chen J, et al. For older adults, pregnant women, people with lung disease, and those at risk for COVID-19 or recovering from it, inhaling wildfire smoke can be dangerous. 2018;18(1):574. https://doi.org/10.1186/s12889-018-5484-8 4. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 United States, February 12 Res. University of California - Davis Health. During the coronavirus disease (COVID-19) pandemic, the issue of tobacco smoking and risk for acute respiratory infection is again topical. 2022 Dec 14;11(24):7413. doi: 10.3390/jcm11247413. https://doi.org/10.1136/bmj.m1091 10. across studies. On . The Quitline provides information, quit coaching, and, for eligible New Yorkers, free starter kits of nicotine replacement therapy (NRT). Med. And, when it comes to the COVID-19 pandemic, the side effects of smoking and the behaviors of people who smoke or vape could create a one-two punch. Lian, Jiangshan, Jin, Xi Analysis of Epidemiological and Clinical Features in Older Patients BMJ. Materials provided by University of California - Davis Health. May 29. Chinese Medical Journal. The .gov means its official. Vardavas et al.40 analysed data from 5 studies totalling 1549 patients and calculated a relative risk that indicated a non-significant & Kachooei, A. R. Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Secondhand smoke has always been a killer, but COVID-19 has made exposure to tobacco smoke potentially deadlier. The immune system is supressed making the lungs less ready to fight a COVID-19 infection (shown above). 343, 3339 (2020). Second, we need more data; many of the H1N1 influenza cohorts did not report on smoking status, which is also the case for many other infectious diseases. Clinical features and treatment 2020 Science Photo Library. "Besides examining associations by type of virus, a key reason we re-analyzed the original British Cold Study is to report a risk ratio instead of an odds ratio," Dove explained. National Library of Medicine Article Allergy 75, 17301741 (2020). These findings are consistent with known harms caused by smoking to immune and respiratory defenses and some observational evidence of increased COVID-19 infection and disease progression in current smokers. The influence of smoking on COVID-19 infection and outcomes is unclear. Avoiding COVID-19 now, but having lung cancer or COPD later on, is not a desired outcome; therefore, any short-term interventions need to have long-term sustainability. Cite this article. 34 analysed data for 5960 hospitalized patients and found a pooled prevalence of 6.5% (1.4% - 12.6%). Nicotine may inhibit the penetration and spread of the virus and have a prophylactic effect in COVID-19 infection. Tobacco smoking and COVID-19 infection Lancet Respir Med. https://doi:10.3346/jkms.2020.35.e142 19. Arch. Information in this post was accurate at the time of its posting. Experts worry that the pandemic interrupted decades of progress in minimizing tobacco use even as smoking heightens the risk of severe COVID-19 illness. Electronic address . This review therefore assesses the available peer-reviewed literature Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Nicotine Tob. There's no way to predict how sick you'll get from COVID-19. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. The evidence remains inconclusive, but it seems that some public health experts and journalists don't want to get to the bottom of this mystery. Most recent smoking status was determined from primary care records (70.8%) and UK Biobank questionnaire data (29.2%). 8(5): 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5 27. The finding that smoking is not associated with SARS-CoV-2 infection contradicts earlier studies which found that smokers are more vulnerable to infections in general and to respiratory infections in particular. A review was conducted on 12 May 2020 on smoking and COVID-19, using MEDLINE, EMBASE, Cochrane Library, and WHO Global Database. 2020. Geneeskd. 2020. https://doi.org/10.32388/WPP19W.3 6. The authors declare no competing interests. Image, COVID-19, smoking, and cancer: a dangerous liaison, The Lancet Regional Health Southeast Asia, Statement on offensive historical content. Complications of Smoking and COVID-19. An official website of the United States government. The study at a major Paris hospital suggests a substance in tobacco - possibly nicotine - may be stopping patients who smoke from catching Covid-19. Could it be possible that SARS-CoV-2 is the big exception to the rule? Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. disappeared when the largest study by Guan et al.13 was removed from the analysis (a sensitivity test to see the impact of a single study on the findings of the meta-analysis). E.M., E.G.M., N.H.C., M.C.W. Please share this information with . 33 analysed data for 2986 patients and found a pooled prevalence of smoking of 7.6% (3.8% -12.4%) while Two meta-analyses reported pooled prevalence of smoking in hospitalized patients using a subset of these studies (between 6 and 13 studies). Mar16. In the year to June 2020, 7.6% of smokers taking part in the survey quit - almost a third higher than the average and the highest proportion since the survey began more than a decade ago. Addresses across the entire subnet were used to download content in bulk, in violation of the terms of the PMC Copyright Notice. eCollection 2023 Jan. J Affect Disord Rep. 2021 Dec;6:100191. doi: 10.1016/j.jadr.2021.100191. Moreover, there is growing evidence that smokers have worse outcomes after contracting the virus than non-smokers3. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. As we confront the coronavirus, it is more important than ever for smokers to quit and for youth and young adults to stop using all tobacco products, including e . There is no easy solution to the spread of health misinformation through social media, but primary healthcare providers (HCPs) can play an important role in mitigating its harmful effects. Tobacco induced diseases. severe infections from Covid-19. MeSH Would you like email updates of new search results? Epub 2021 Jul 24. Table 2 Relative risk of confirmed COVID-19 cases by tobacco use in participants of FinSote surveys. Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners. npj Prim. 2020. Cigarette smoking and secondhand smoke cause disease, disability, and death. government site. PubMed Central Banning tobacco sales might not be wholly effective if people are still able to access cigarettes and so other measures need to be implemented to discourage tobacco use. in SARS-CoV-2 infection: a nationwide analysis in China. In other words, the findings may not be generalizable to other coronaviruses. Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, et al. Smoking is also a well-established risk fac-tor for chronic diseases that are linked to more severe COVID-19. Irrespective of COVID-19, smoking is uniquely deadly. 2. 2020;21(3):335-7. https://doi.org/10.1016/S1470-2045(20)30096-6 21. Additionally., infected individuals who stop smoking immediately prior to testing or hospitalization are often recorded as a non-smoker or former smoker. Cancer patients Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Methods Univariable and . "Odds ratios may overestimate the strength of an association if an event is not rare (>10%), so our results are a little lower (1.48 compared with 2.1 in the BCS). 8, e35 (2020). Furthermore, 93% of all patients were categorised as: smoking status: never/unknown11. Bommel, J. et al. volume31, Articlenumber:10 (2021) Underner M, Peiffer G, Perriot J, Jaafari N. Rev Mal Respir. "Smoking is associated with substantially higher risk of COVID-19 progression," said Stanton A. Glantz, PhD, professor of medicine and director of the UCSF Center for Tobacco Control Research and Education. Y, Zhang Z, Tian J, Xiong S. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Preliminary Report of the First 28 Patients from the Korean Cohort Study Correspondence to A new study led by UC Davis Comprehensive Cancer Center researchers shows that current smokers have a 12% increased risk of a laboratory-confirmed viral infection and a 48% increased risk of being diagnosed with respiratory illnesses. Alharbi AS, Altwaim SA, Alharbi AS, Alsulami S. Cureus. Here, we suggest a few steps to help reduce tobacco use during this pandemic and hopefully long after. Clinical infectious diseases : an official publication of the Infectious Diseases Society Eur. Exposure to health misinformation about COVID-19 and increased tobacco and alcohol use: a population-based survey in Hong Kong. Tob. Tob. which are our essential defenders against viruses like COVID-19. The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. Han L, Ran J, Mak YW, Suen LK, Lee PH, Peiris JSM, et al. Arch. May 3. https://doi:10.1093/cid/ciaa539 16. government site. Nicotine Tob. A review of studies by public health experts convened by WHO on 29 April 2020 found that smokers are more likely to develop severe disease with COVID-19, compared to non-smokers. Given the well-established harms associated with tobacco use and second-hand smoke exposure;2 WHO recommends that tobacco users stop using tobacco. J. Med. 18, 63 (2020). "Past research has shown that smoking increases the risk of COVID-19 disease severity, but the risk of infection had been less clear," said UC Davis tobacco researcher and lead author of the study . calculation and concluded that this association was indeed statistically significant (OR 2.2 (95% CI 1.3 3.7). Observational studies have limitations. One such risk factor is tobacco use, which has been . Smoking weakens the immune system, which makes it harder for your body to fight disease. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis, Tobacco use and risk of COVID-19 infection in the Finnish general population, Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study, Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts, Collider bias undermines our understanding of COVID-19 disease risk and severity, Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study, COVID-19 and kidney disease: insights from epidemiology to inform clinical practice, Estimating the risk of incident SARS-CoV-2 infection among healthcare workers in quarantine hospitals: the Egyptian example, SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic, https://www.biorxiv.org/content/10.1101/2020.11.23.394577v3, https://www.medrxiv.org/content/10.1101/2020.09.04.20188771v4, https://doi.org/10.1136/tobaccocontrol-2020-055960, https://ggtc.world/2020/03/24/covid-19-and-tobacco-industry-interference-2020/, https://www.medrxiv.org/content/10.1101/2020.03.09.20033118v1, http://creativecommons.org/licenses/by/4.0/, Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre casecontrol study, A virus-free cellular model recapitulates several features of severe COVID-19. 2020. RNvZ-S reports personal fees from Novartis, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Cipla, Merck Sharpe & Dohme, and Pfizer, outside of the submitted work. Careers. Explore Surgeon General's Report to find latest research. Chest CT Findings in Patients with Coronavirus Disease 2019 and Its Relationship with Clinical Features. Apr 23;S0163-4453(20)30234-6. https://doi:10.1016/j.jinf.2020.04.021 38. Low rate of daily active tobacco smoking in patients with symptomatic COVID-19. UC Davis tobacco researcher Melanie Dove. We investigated the association between smoking and COVID-19 during an outbreak of the disease on a naval vessel. Ned. Emami, A., Javanmardi, F., Pirbonyeh, N. & Akbari, A. He says the COVID-19 pandemic is an opportunity for people who smoke to recognize the serious health risks associated with the addiction and consider quitting. Guan et al. First, in line with national guidelines, primary HCPs can choose to ask patients about their smoking status during consultations, inform smokers about the dangers of smoking, advise smokers to quit smoking and offer cessation support to all smokers.